Benzinga | Jan 15, 2021 06:31AM EST

Thermo Fisher Scientific Completes Acquisition Viral Vector Manufacturing Business From Novasep For 00E2725M In Cash

WALTHAM, Mass. and LYON, France, Jan. 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplierWALTHAM, Mass. and LYON, France, Jan. 15, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc., (NYSE:TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business in Belgium for approximately (euro)725 million in cash.